APA

Zhang S., Zhu L., Xia B., Chen E., Zhao Q., Zhang X., Chen X., Chen X. & Ma S. (20190211). Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study. : Cancer communications (London, England).

Chicago

Zhang Shirong, Zhu Lucheng, Xia Bing, Chen Enguo, Zhao Qiong, Zhang Xiaochen, Chen Xueqin, Chen Xufeng and Ma Shenglin. 20190211. Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study. : Cancer communications (London, England).

Harvard

Zhang S., Zhu L., Xia B., Chen E., Zhao Q., Zhang X., Chen X., Chen X. and Ma S. (20190211). Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study. : Cancer communications (London, England).

MLA

Zhang Shirong, Zhu Lucheng, Xia Bing, Chen Enguo, Zhao Qiong, Zhang Xiaochen, Chen Xueqin, Chen Xufeng and Ma Shenglin. Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study. : Cancer communications (London, England). 20190211.